An oral dosage form of Taxol, an anti-cancer drug, has been newly developed with much less adverse reactions.
In the 3rd Joint Korea and Japan International symposium at Hoam faculty club house, SNU sponsored by the Korea Society of Pharmaceutics on April 20, Dr. Chung Hae-seon of KIST presented her study paper titled "A development of an oral anti-cancer drug", attracting keen interests to ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.